Gara Jalqabaatti › Kansera Urothelial (Cell Transitional) › Ohio › Cleveland
Qorannoo klinikaalii Kansera Urothelial (Cell Transitional) Cleveland, OH keessatti
Qorannoo 8 Kansera Urothelial (Cell Transitional) f Cleveland fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Exelixis Clinical Site #10, Cleveland
Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
Namoota walitti qabaa jira
- University Hospitals Cleveland Medical Center, Urology Institute, Case Comprehensive Cancer Center, Cleveland
- Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
Namoota walitti qabaa jiraSadarkaa 1/2
- Cleveland Clinic-Taussig Cancer Center ( Site 1036), Cleveland
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Foundation, Cleveland
- Cleveland Clinic Taussig Cancer Center Investigational Pharmacy, Cleveland
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
Namoota walitti qabaa jiraSadarkaa 1
- Cleveland Clinic, Cleveland
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Namoota walitti qabaa jiraSadarkaa 2
- University Hospitals Cleveland Medical Center, Cleveland
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Mayfield Heights · Miili 12 fagaatti
Qorannoo Kansera Urothelial (Cell Transitional) magaalota biroo keessatti
- Nashville, TNQorannoo 23
- New York City, NYQorannoo 22
- Houston, TXQorannoo 19
- Dallas, TXQorannoo 18
- Edison, NJQorannoo 18
- Los Angeles, CAQorannoo 17
- Queens, NYQorannoo 15
- Chicago, ILQorannoo 14
- Arlington, VAQorannoo 12
- Boston, MAQorannoo 11
- San Antonio, TXQorannoo 11
- Austin, TXQorannoo 10
Qorannoo biroo Cleveland keessatti
- Kansara Qara'a Non-Small CellQorannoo 43
- Saree (Gosoota Hunda)Qorannoo 36
- Saree OljooQorannoo 35
- Kansarii ProstateQorannoo 34
- Cufama OnneeQorannoo 33
- Kansarii OvariiQorannoo 30
- Kansara MetastatikiiQorannoo 30
- Dhibee QaraQorannoo 26
- Kansarii ColorectalQorannoo 24
- Dhibee Onneessaa fi DhiigaQorannoo 22
- Kansa EndometiriyaaliiQorannoo 20
- Leukemia Myeloidii HamaaQorannoo 20
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.